Pongpunna Supawinee, Pratipanawatr Thongchai, Wongtaweepkij Kamonphat, Jarernsiripornkul Narumol
Division of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Khon Kaen University, Khon Kaen, Thailand.
Department of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
Patient Prefer Adherence. 2021 Oct 28;15:2377-2387. doi: 10.2147/PPA.S334668. eCollection 2021.
This study aimed to evaluate the effect of using atorvastatin PIL on patients' medication knowledge, perceptions of the PIL usefulness, their anxiety about the medication, and factors related to these aspects.
A pre-post intervention study was conducted in outpatients at a university hospital. Patients prescribed atorvastatin were enrolled using systematic random sampling. Participants were asked to complete Self-Administered Questionnaire to assess atorvastatin knowledge at baseline. An atorvastatin-PIL produced by the manufacturer was introduced to the participants as the intervention. One month after receiving the PIL, the participants were re-assessed. Ten questions were developed to assess atorvastatin knowledge and visual analog scale (VAS) was used to assess perceived benefits of using the PIL and patient anxiety about the medication. Multiple linear regression was used to assess the related factors.
Of 450 questionnaires distributed, 370 were returned. Atorvastatin knowledge significantly increased with mean score of 5.06±1.92 at baseline to 8.34±1.79 at 1-month after intervention. Reading all sections of the PIL (p=0.017) and working for civil service (p=0.006) were associated with higher knowledge scores at baseline and after intervention. Low educational level was associated with lower knowledge scores at baseline (p=0.002), but experience of allergy (p=0.042) was associated with higher knowledge scores after the intervention. Patients had high level of perceived usefulness from the PIL (average scores=8.87±1.83) and low level of anxiety (average scores=3.69±3.06). Reading all sections of the PIL (p=0.007) and taking more than 5 medications (p=0.012) were related to perceived usefulness of the PIL. Females (p<0.001) and herbal supplement users (p=0.048) were related to anxiety about the medication.
PILs could improve medication knowledge in patients. Patients' perceptions of benefits of PILs were high and anxiety about medication was low. Use of PILs should be encouraged to improve patients' knowledge and appropriate use of medications.
本研究旨在评估使用阿托伐他汀患者用药指导(PIL)对患者用药知识、对PIL有用性的认知、对药物的焦虑以及与这些方面相关因素的影响。
在一家大学医院的门诊患者中进行了一项干预前后研究。使用系统随机抽样法招募开具阿托伐他汀处方的患者。参与者被要求在基线时完成自填问卷以评估阿托伐他汀知识。将制造商生产的阿托伐他汀-PIL作为干预措施介绍给参与者。在收到PIL一个月后,对参与者进行重新评估。编制了10个问题来评估阿托伐他汀知识,并使用视觉模拟量表(VAS)来评估使用PIL的感知益处和患者对药物的焦虑。采用多元线性回归来评估相关因素。
共发放450份问卷,回收370份。阿托伐他汀知识显著增加,基线时平均分为5.06±1.92,干预后1个月时为8.34±1.79。阅读PIL的所有章节(p = 0.017)和从事公务员工作(p = 0.006)与基线时和干预后的较高知识得分相关。低教育水平与基线时较低的知识得分相关(p = 0.002),但过敏经历(p = 0.042)与干预后较高的知识得分相关。患者对PIL的感知有用性较高(平均得分 = 8.87±1.83),焦虑程度较低(平均得分 = 3.69±3.06)。阅读PIL的所有章节(p = 0.007)和服用超过5种药物(p = 0.012)与PIL的感知有用性相关。女性(p < 0.001)和使用草药补充剂者(p = 0.048)与对药物的焦虑相关。
PIL可提高患者的用药知识。患者对PIL益处的认知较高,对药物的焦虑较低。应鼓励使用PIL以提高患者的知识水平和合理用药。